Dr. Kueck is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Trinity Health Iha Medical Group Gynecology Oncology
5303 Elliot Drive Suite 220
Ypsilanti, MI 48197Phone+1 734-712-2005Fax+1 734-712-2013
Summary
- Angela Kueck, MD is an obstetrics and gynecology specialist with a subspecialty in gynecologic oncology, based in Ypsilanti, MI. She completed her education at Georgetown University School of Medicine and furthered her training at Georgetown University Hospital and University of Michigan Health System. She is currently associated with St. Joseph Mercy Ann Arbor. Dr. Kueck has contributed to a number of publications on topics such as sexual health, mental health, ovarian cancer, and gynecologic cancers. She has also been involved in multiple clinical trials concerning ovarian, fallopian tube, and primary peritoneal cancer. She has been recognized as a top doctor in her region, and is a fellow of both the American Congress of Obstetricians and Gynecologists and the American College of Surgeons.
Education & Training
- University of MichiganFellowship, Gynecologic Oncology, 2003 - 2006
- Georgetown University HospitalResidency, Obstetrics and Gynecology, 1999 - 2003
- Georgetown University School of MedicineClass of 1999
Certifications & Licensure
- MI State Medical License 2003 - 2026
- TX State Medical License 2016 - 2025
- CT State Medical License 2010 - 2016
- OH State Medical License 2005 - 2008
- VA State Medical License 1999 - 2003
- American Board of Obstetrics and Gynecology Obstetrics & Gynecology
- American Board of Obstetrics and Gynecology Gynecologic Oncology
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
- Fellow (FACS) American College of Surgeons
- Fellow (FACOG) American Congress of Obstetricians and Gynecologists
Clinical Trials
- Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer Start of enrollment: 2005 Mar 21
- Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Start of enrollment: 2007 Dec 06
- Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2012 Jun 18
- Join now to see all
Publications & Presentations
PubMed
- 390 citationsAldehyde dehydrogenase in combination with CD133 defines angiogenic ovarian cancer stem cells that portend poor patient survival.Ines A. Silva, Shoumei Bai, Karen McLean, Kun Yang, Kent A. Griffith
Cancer Research. 2011-06-01 - 55 citationsResveratrol inhibits ovarian tumor growth in an in vivo mouse model.Lijun Tan, Weimin Wang, Gong He, Rork Kuick, Gabrielle Gossner
Cancer. 2016-03-01 - 114 citationsResveratrol inhibits glucose metabolism in human ovarian cancer cells.Angela Kueck, Anthony W. Opipari, Kent A. Griffith, Lijun Tan, Milheon Choi
Gynecologic Oncology. 2007-12-01
Press Mentions
- Cancer-related Death Rates Trending Down in TexasJanuary 30th, 2023
- How One App Is Helping to Tighten the Link Between Cancer Patients and Their DoctorsSeptember 4th, 2017
- Immunotherapy Helps Woman Fight Deadly Ovarian CancerMarch 1st, 2017
- Join now to see all
Professional Memberships
- Member
- Fellow
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: